. Brit. J. industr. Med., 29,[225][226][227][228]. Chronic inorganic mercury poisoning treated with N-acetyl-D-penicillamine. The case history is presented of a man intoxicated by mercury during his employment as a filler of thermometers. The mean daily urinary excretion of mercury was 661 ,ug for five estimations before treatment. The mean excretion was 875 ,ug for the first 10 days after beginning N-acetyl-D-p_nicillamine, 600 mg/day. This difference is not significant (P < 0 1). The literature of the treatment of mercury poisoning is briefly reviewed.
finally to the trunk and head. His speech became tremulous, his writing deteriorated, and his gait became unsteady. One month later (January 1968) he became increasingly nervous and timid of others, and was having so much difficulty doing his job that he left his employment. After a further month he was seen at the National Hospital for Nervous Diseases and was subsequently admitted.
On examination he was noted to be generally pigmented, nervous, timid, and excitable. His tongue was red and swollen, and there was a severe gingivitis with dark blue discolouration on the inside of the lips (Fig. 1 ). His speech was tremulous and he had a marked coarse, irregular tremor of the head, trunk, and limbs at a frequency of about 6 cycles per second. The tremor was worse on voluntary movement. His gait was ataxic and his writing severely affected (Fig. 2, could spray a considerable distance, and droplets of spilled mercury were found on and around his work bench, and in cracks in the floor nearly 20 feet distant.
The patient was naturally shy and became more so as intoxication progressed so that he preferred to eat his sandwiches at his workbench rather than in the canteen. The only other man doing a similar job had been there 17 years. When examined briefly he showed no signs or symptoms of intoxication apart from a slight tremor of the hands.
Diagnosis
It is generally accepted that urinary concentrations of mercury in excess of 100 Htg per litre are abnormal, and toxic symptoms usually accompany levels in excess of 300 ,tg per litre (Noe, 1960) .
In the presence of a constant exposure level, different levels of mercury can be excreted by the same person on different days (Battigelli, 1960); and Noe (1960) advises that at least six estimations should be performed. This point was substantiated in our patient, in whom urinary levels fluctuated almost threefold in the first five estimations (406 to 1 015 ,ug) but were all nevertheless in excess of 300 ,ug per litre. However, difficulties can arise from the fact that, for a given level of exposure, different people excrete different amounts of mercury (Battigelli, 1960; Parameshvara, 1967) ; and, furthermore, for a given vapour concentration women tend to excrete greater amounts than men (Noe, 1960) .
Treatment
Prophylactic measures constitute the most important forms of treatment, which include an awareness of the potential hazards and symptoms of mercury poisoning and the provision of adequate protection at work (Cumings, 1959; Noe, 1960) . Once a case of poisoning is diagnosed, the patient should immediately be removed from his environment. In many instances, and for reasons mentioned above, this will already have occurred (Cumings, 1959) .
As far as specific measures are concerned, there appears to be little doubt of the efficacy of the chelating agent and -SH group inhibitor, dimercaprol, in the treatment of acute intoxication (Battigelli, 1960; Pagnotto et al., 1960) . The value of this drug and of sodium calcium edetate in improving the clinical state and increasing the urinary excretion of mercury, in chronic poisoning, is more doubtful (Woodcock, 1958; Battigelli, 1960; Pagnotto et al., 1960; Kazantzis, 1965) .
A more recent therapeutic development has been the use of penicillamine following the suggestion by Walshe (1956) that this drug might be useful in mercury poisoning. Aposhian and Aposhian (1959) showed that N-acetyl-D,Lpenicillamine could protect rats against the acute effects of mercuric chloride. Pagnotto et al. (1960) reported the clinical use of this drug in two patients with chronic mercury poisoning. In their first patient, the average urinary excretion of mercury increased from 1 200,ug to 2 120 ,ug per day when given Ig N-acetyl-D,L-penicillamine per day. These figures represent the mean of an unstated number of observations. The urinary excretion of their second patient, given 3g per day, increased from 610,ug to 800,ug per day averaged over three days. Single patients treated with N-acetyl-D,L-penicillamine have also been reported by Smith and Miller (1961) and Parameshvara (1967 The mean daily urinary output of mercury in our patient was 661 ,ug for five estimations before beginning N-acetyl-D-penicillamine and was 875 ,ug for the first 10 days after beginning this drug. The difference is not significant (p < 0-1). In view of the little further clinical improvement, the falling levels of urinary mercury, and the known toxic effects of N-acetyl-D-penicillamine, it was discontinued after 80 days.
Discussion
It is clear that, on the basis of the limited number of patients so far reported, treatment with N-acetyl-Dor N-acetyl-D,L-penicillamine cannot be shown to alter significantly the naturally occurring variation in urinary excretion of mercury and, moreover, it is extremely difficult to evaluate any clinical benefits in view of the natural tendency to improvement on removal from exposure. Indeed this simple manoeuvre itself has been seen to result in some patients making a complete clinical recoveiy (Kazantzis, 1965) . Dimercaprol has been shown experimentally to have little effect on elimination of intracellular mercury (Battigelli, 1960) , and a similar situation might well prevail in the case of penicillamine. Indeed the value of this form of therapy may be as a means of combining with, inactivating, and assisting elimination of extracellular mercury. In view of the rarity of chronic mercury poisoning, and the ethics of withholding possible effective therapy, the real value of such agents will probably be resolved only on the basis of controlled animal experiments.
There is very little information regarding the long-term prognosis of both the tremor and erethism, though this would appear to vary with the severity at the time of diagnosis. From a series of 135 patients, Baldi, Vigliani, and Zurlo (1953) reported that only 15% of patients with marked symptoms of intoxication showed any improvement when followed up from four to five years. In view of this fact, and the severe degree of intoxication seen in our patient, we feel that the ultimate prognosis should remain guarded.
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In this study, the patient was treated with 1 000 mg per day for three courses each of 10 days, followed by one course of 2 000 mg per day. Clinical improvement coincided with the administration of the first of these courses. Faecal mercury excretion was not significantly increased. The authors' Fig. 4 shows that the daily urinary excretion of mercury before the administration of the drug was about 1430, 1 680, and 2 080 ,tg. During the first 10-day course of penicillamine the urinary excretion exceeded 2 000 ,ug on only two days and was less than 1 600 ttg on five days. The effect of the second course was equally modest. Their Fig. 4 also shows that the third and fourth courses had no effect on the urinary excretion of mercury.
These results do not suggest that the urinary excretion of mercury is increased over a long period of time by N-acetyl-D,L-penicillamine, though the drug may be of value in hastening the excretion of an easily mobilizable extracellular pool.
